Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 811-820 of 2916 for cancer

Edit search filters
  1. A Study To Determine The Best Individualized Cancer Therapy Using Circulating Tumor DNA (CtDNA) In Patients With GI, CNS, And Thoracic Cancers.

    Jacksonville, FL

  2. Surgery With Or Without Neoadjuvant Chemotherapy In High Risk RetroPeritoneal Sarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. TransCon (TC) TLR7/​8 Agonist, TC IL-2 Β/​γ, Pembrolizumab Prior To Surgery For Advanced Head And Neck Squamous Cell Carcinoma (BelieveIT-201)

    Rochester, MN

  4. Study Of INBRX-109 In Conventional Chondrosarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Advancing Skin Cancer Prevention And Treatment Through DNA Repair Enzymes: A Clinical Approach In Solid Organ Transplant Recipients

    Jacksonville, FL

  6. A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, And Elotuzumab, Pomalidomide, And Dexamethasone Or Pomalidomide, Bortezomib, And Dexamethasone In Participants With Relapsed Or Refractory Myeloma Who Have Received An Anti-CD38 Antibody And Lenalidomide

    Rochester, MN

  7. A Study To Evaluate Lasofoxifene Versus Fulvestrant In Advanced Or Metastatic ER+/HER2− Breast Cancer Patients With An ESR1 Mutation

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study To Evaluate Exercise For Cancer Patients At Risk Of Falling

    Rochester, MN

  9. IMC-F106C Regimen Versus Nivolumab Regimens In Previously Untreated Advanced Melanoma (PRISM-MEL-301)

    Jacksonville, FL

  10. A Phase 3 Study To Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy In Previously Treated Head And Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer